Fcpm Iii Services B.V. Astria Therapeutics, Inc. Transaction History
Fcpm Iii Services B.V.
- $369 Billion
- Q2 2025
A detailed history of Fcpm Iii Services B.V. transactions in Astria Therapeutics, Inc. stock. As of the latest transaction made, Fcpm Iii Services B.V. holds 4,107,537 shares of ATXS stock, worth $50.3 Million. This represents 6.34% of its overall portfolio holdings.
Number of Shares
4,107,537
Previous 3,822,537
7.46%
Holding current value
$50.3 Million
Previous $20.4 Billion
14.7%
% of portfolio
6.34%
Previous 4.93%
Shares
3 transactions
Others Institutions Holding ATXS
# of Institutions
110Shares Held
49.3MCall Options Held
6.6KPut Options Held
0-
Perceptive Advisors LLC New York, NY6.49MShares$79.4 Million1.53% of portfolio
-
Vestal Point Capital, LP New York, NY4.52MShares$55.4 Million1.28% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA3.55MShares$43.5 Million5.84% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$43.1 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.97MShares$36.4 Million0.01% of portfolio
About Astria Therapeutics, Inc.
- Ticker ATXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,178,000
- Market Cap $186M
- Description
- Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage...